Cargando…
Examples of adverse effects after biological therapy
Psoriasis is one of the most common, chronic skin diseases of as yet unexplained etiopathogenesis. In the recent years it has been proven that an immunological factor plays an important role in the dermatosis onset. This has led to introduction of biological drugs to the disease treatment regimen, w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675069/ https://www.ncbi.nlm.nih.gov/pubmed/33240011 http://dx.doi.org/10.5114/ada.2020.100482 |
_version_ | 1783611638114418688 |
---|---|
author | Hadas, Ewa Bozek, Andrzej Cudak, Anna Ciuk, Aleksandra Jarząb, Jerzy |
author_facet | Hadas, Ewa Bozek, Andrzej Cudak, Anna Ciuk, Aleksandra Jarząb, Jerzy |
author_sort | Hadas, Ewa |
collection | PubMed |
description | Psoriasis is one of the most common, chronic skin diseases of as yet unexplained etiopathogenesis. In the recent years it has been proven that an immunological factor plays an important role in the dermatosis onset. This has led to introduction of biological drugs to the disease treatment regimen, which include, inter alia, adalimumab and ustekinumab. New therapy has become an alternative for patients with psoriasis resistant to standard treatment methods as well as an alternative form of treatment in case of occurrence of severe adverse drug reactions after administration of standard treatment. Despite good treatment results the administration of these drugs is associated with the occurrence of adverse reactions. This article presents cases of 4 patients who have been administered biological treatment and in whom there have been observed, inter alia, the occurrence of hypersensitivity reactions in the form of acute urticaria as well as skin lesions of erythema multiforme nature or positive antinuclear antibodies titre. The symptoms experienced by the presented patients posed no direct threat to life and the benefits of the drugs’ administration had a significant therapeutic importance. |
format | Online Article Text |
id | pubmed-7675069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-76750692020-11-24 Examples of adverse effects after biological therapy Hadas, Ewa Bozek, Andrzej Cudak, Anna Ciuk, Aleksandra Jarząb, Jerzy Postepy Dermatol Alergol Original Paper Psoriasis is one of the most common, chronic skin diseases of as yet unexplained etiopathogenesis. In the recent years it has been proven that an immunological factor plays an important role in the dermatosis onset. This has led to introduction of biological drugs to the disease treatment regimen, which include, inter alia, adalimumab and ustekinumab. New therapy has become an alternative for patients with psoriasis resistant to standard treatment methods as well as an alternative form of treatment in case of occurrence of severe adverse drug reactions after administration of standard treatment. Despite good treatment results the administration of these drugs is associated with the occurrence of adverse reactions. This article presents cases of 4 patients who have been administered biological treatment and in whom there have been observed, inter alia, the occurrence of hypersensitivity reactions in the form of acute urticaria as well as skin lesions of erythema multiforme nature or positive antinuclear antibodies titre. The symptoms experienced by the presented patients posed no direct threat to life and the benefits of the drugs’ administration had a significant therapeutic importance. Termedia Publishing House 2020-11-07 2020-10 /pmc/articles/PMC7675069/ /pubmed/33240011 http://dx.doi.org/10.5114/ada.2020.100482 Text en Copyright © 2020 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Original Paper Hadas, Ewa Bozek, Andrzej Cudak, Anna Ciuk, Aleksandra Jarząb, Jerzy Examples of adverse effects after biological therapy |
title | Examples of adverse effects after biological therapy |
title_full | Examples of adverse effects after biological therapy |
title_fullStr | Examples of adverse effects after biological therapy |
title_full_unstemmed | Examples of adverse effects after biological therapy |
title_short | Examples of adverse effects after biological therapy |
title_sort | examples of adverse effects after biological therapy |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675069/ https://www.ncbi.nlm.nih.gov/pubmed/33240011 http://dx.doi.org/10.5114/ada.2020.100482 |
work_keys_str_mv | AT hadasewa examplesofadverseeffectsafterbiologicaltherapy AT bozekandrzej examplesofadverseeffectsafterbiologicaltherapy AT cudakanna examplesofadverseeffectsafterbiologicaltherapy AT ciukaleksandra examplesofadverseeffectsafterbiologicaltherapy AT jarzabjerzy examplesofadverseeffectsafterbiologicaltherapy |